Abstract
People with diabetes have a marked increase in morbidity and mortality. The American Diabetes Association has recommended evidence-based process and outcome measures to improve diabetes care. However, these are not met in the majority of patients under our current medical care system. There have been many (mostly unsuccessful) approaches to improving these outcomes including reminding patients about appointments, feeding back information on the patient to the physician, even when specific treatment recommendations for the individual patient were included, case management (when the case manager could not make treatment decisions), education of physicians and multifaceted quality improvement interventions in the practice setting. One approach has consistently been successful; case management when a nurse or pharmacist had the authority to make independent treatment decisions. In randomized clinical trials, Hb A1c levels were lowered approximately three times as much by nurses or pharmacists following approved detailed treatment algorithms (under the supervision of a physician) compared to usual care. Given the approaching epidemic of diabetes, our medical care system should strongly consider this approach to improving diabetes care to forestall the devastation of diabetic complications and the overwhelming costs of caring for these patients.
Keywords: Diabetes disease management, Nurse- and pharmacist-directed diabetes care, Quality of diabetes care
Current Diabetes Reviews
Title: The Effectiveness of Nurse- and Pharmacist-Directed Care in Diabetes Disease Management:A Narrative Review
Volume: 3 Issue: 4
Author(s): Mayer B. Davidson
Affiliation:
Keywords: Diabetes disease management, Nurse- and pharmacist-directed diabetes care, Quality of diabetes care
Abstract: People with diabetes have a marked increase in morbidity and mortality. The American Diabetes Association has recommended evidence-based process and outcome measures to improve diabetes care. However, these are not met in the majority of patients under our current medical care system. There have been many (mostly unsuccessful) approaches to improving these outcomes including reminding patients about appointments, feeding back information on the patient to the physician, even when specific treatment recommendations for the individual patient were included, case management (when the case manager could not make treatment decisions), education of physicians and multifaceted quality improvement interventions in the practice setting. One approach has consistently been successful; case management when a nurse or pharmacist had the authority to make independent treatment decisions. In randomized clinical trials, Hb A1c levels were lowered approximately three times as much by nurses or pharmacists following approved detailed treatment algorithms (under the supervision of a physician) compared to usual care. Given the approaching epidemic of diabetes, our medical care system should strongly consider this approach to improving diabetes care to forestall the devastation of diabetic complications and the overwhelming costs of caring for these patients.
Export Options
About this article
Cite this article as:
Davidson B. Mayer, The Effectiveness of Nurse- and Pharmacist-Directed Care in Diabetes Disease Management:A Narrative Review, Current Diabetes Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339907782330058
DOI https://dx.doi.org/10.2174/157339907782330058 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cell-Replacement Therapy with Stem Cells in Neurodegenerative Diseases
Current Neurovascular Research Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals
Current Gene Therapy Impact of Metformin on Male Reproduction
Current Pharmaceutical Design Small Molecules Activating TrkB Receptor for Treating a Variety of CNS Disorders
CNS & Neurological Disorders - Drug Targets Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry Molecular Mechanism Aspect of ER Stress in Alzheimer's Disease: Current Approaches and Future Strategies
Current Drug Targets Pharmacologic Intervention in Axonal Excitability: In Vivo Assessment of Nodal Persistent Sodium Currents in Human Neuropathies
Current Molecular Pharmacology Nutritional Approaches to Modulate Oxidative Stress in Alzheimers Disease
Current Alzheimer Research Identification of Potent Caspase-3 Inhibitors for Treatment of Multi- Neurodegenerative Diseases Using Pharmacophore Modeling and Docking Approaches
CNS & Neurological Disorders - Drug Targets Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
Current Diabetes Reviews Anti-inflammatory Glycosylated Flavonoids as Therapeutic Agents for Treatment of Diabetes-Impaired Wounds
Current Topics in Medicinal Chemistry Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Cell Cycle Re-Entry in Alzheimers Disease: A Major Neuropathological Characteristic?
Current Alzheimer Research Current Concepts in Gastric Motility in Diabetes Mellitus
Current Diabetes Reviews Plasma Glucose Concentrations and Cardiac Hypertrophy in Essential Hypertension
Current Hypertension Reviews Chaperone Therapy: New Molecular Therapy for Protein Misfolding Diseases with Brain Dysfunction
Current Bioinformatics